Current Challenges and Opportunities in Treating Glioblastoma | Pharmacological Reviews
Telix presents IPAX-1 study in glioblastoma treatment at ASCO 2020
Clinical trials for glioblastoma may be missing a common and aggressive molecular subtype
Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report in: Neurosurgical Focus Volume 50 Issue 2 (2021) Journals
Immunotherapy clinical trials for glioblastoma multiforme | Download Table
Clinical implication of cellular vaccine in glioma: current advances and future prospects | Journal of Experimental & Clinical Cancer Research | Full Text
Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer
4 Glioblastoma Clinical Trials to Watch – Consult QD
Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy - ScienceDirect
Clinical Trials | The Preston Robert Tisch Brain Tumor Center
Adult Glioblastoma | Journal of Clinical Oncology
New Approach Could Help in Treating Glioblastoma, Other Rare Cancers
New approaches to immunotherapy for glioblastoma - Mayo Clinic
References in Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter? - Radiotherapy and Oncology
When is the Best Time to Seek a Clinical Trial for Glioblastoma? - Cancer Commons
Timeline of clinical trials for glioma using immunotherapy | Download Scientific Diagram
Cancers | Free Full-Text | Advances in Immunotherapy for Adult Glioblastoma | HTML
Active clinical trials for gene therapy of GBM. Clinical trials listed... | Download Table
Frontiers | CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma | Neuroscience
GBM AGILE - Global Coalition for Adaptive Research
Frontiers | Current Immunotherapies for Glioblastoma Multiforme | Immunology
Novocure's Tumor Treating Fields: Innovative brain cancer therapy with survival and safety benefits
